Address: 504, Peninsula TowersPeninsula Corporate ParkGanpatrao Kadam Marg, Lower ParelIND – Mumbai 400 013,India
Tel: +91 22 40 49 11 11
At UCB our sense of purpose is to help people suffering from severe central nervous system or immunological disorders lead normal, everyday lives. Our ambition is to offer them innovative new medicines and ground-breaking solutions that go beyond the drug. We are committed to enabling cutting-edge scientific research that is driven by the patients’ needs.
UCB, headquartered in Brussels, Belgium, is a global biopharma company with a team of over 8500 talented employees, a strong market presence in more than 40 countries, € 3.2 billion in revenue (2010) and numerous strategic partnerships across the industry.
We combine biology and chemistry to make major breakthroughs.
By integrating our expertise in large, antibody-based molecules and small, chemically-derived molecules, we can offer families with severe diseases and their specialist physicians the advantages of both large and small molecules to produce extraordinary breakthroughs.
We partner with the leaders in the pharmaceutical industry.
The complexities of severe diseases are beyond the expertise and resources of a single organisation. That is why we have teamed up with partners – we play to our strengths and tap into the organisations with greater or complementary strengths.
UCB’s medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field.
Restless Legs Syndrome
Regulating cerebral functions
Metadate CD™ (methylphenidate HCl) (CII)
Attention Deficit Hyperactivity Disorder (ADHD)
Cimzia® (certolizumab pegol)
Tussionex™ (hydrocodone polistirex and chlorpheniramine polistirex) (CIII)
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…
One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…
Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and…
Dr. Satyanarayana Chava, founder and CEO of Laurus Labs, provides insights into the distinctive model that has…
Luca Visini, the recently appointed managing director of Eli Lilly & Company for India, shares with us his…
Dr. Letitia Robinson, Director of the US FDA India Office, provides insights into the main goals and…